Juul Holst Group

Read more
201 - 225 out of 566Page size: 25
Sort by: 1st author
  1. Published

    GIP infusion in patients with type 1 diabetes seems to attenuate post-prandial glucose excursions after prandial insulin over-dose and physical activity

    Hoe, B., Heimburger, S. M. N., Gasbjerg, L. S., Lanng, A. R., Lynggaard, M. B., Hartmann, Bolette, Holst, Jens Juul, Vilsbøll, Tina, Lund, A., Engberg, S., Dejgaard, T. F., Christensen, Mikkel Bring & Knop, Filip Krag, 2020, In: Diabetologia. 63, Suppl. 1, p. S117 1 p., 232.

    Research output: Contribution to journal › Conference abstract in journal › Research

  2. Published

    Proglucagon processing in porcine and human pancreas

    Holst, Jens Juul, Bersani, M., Johnsen, A. H., Kofod, H., Hartmann, Bolette & Ørskov, Cathrine, 1994, In: Journal of Biological Chemistry. 269, 29, p. 18827-33 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Physiology of the Incretin Hormones, GIP and GLP-1-Regulation of Release and Posttranslational Modifications

    Holst, Jens Juul, Albrechtsen, Nicolai Jacob Wewer, Rosenkilde, Mette & Deacon, Carolyn F., 2019, In: Comprehensive Physiology. 9, 4, p. 1339-1381

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    What is Diabetes Remission?

    Holst, Jens Juul & Madsbad, Sten, 2021, In: Diabetes Therapy. 12, p. 641-646 6 p.

    Research output: Contribution to journal › Comment/debate › Research › peer-review

  5. Published

    Methods and Guidelines for Measurement of Glucagon in Plasma

    Holst, Jens Juul & Albrechtsen, Nicolai Jacob Wewer, 2019, In: International Journal of Molecular Sciences (Online). 20, 10 p., 5416.

    Research output: Contribution to journal › Review › Research › peer-review

  6. Published

    Secretion and Impact of Gut Hormones in Obesity and Diabetes

    Holst, Jens Juul, 2023, Encyclopedia of Cell Biology: Systems, Translational and Specialized Cell Aspects of Cell Biology. Bradshaw, R. A., Hart, G. W. & Stahl, P. D. (eds.). 2 ed. Elsevier, Vol. 6. p. 543-550 8 p.

    Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review

  7. Published

    What combines best with GLP-1 for obesity treatment: GIP receptor agonists or antagonists?

    Holst, Jens Juul, 2021, In: Cell Reports Medicine. 2, 5, 2 p., 100284.

    Research output: Contribution to journal › Comment/debate › Research

  8. Published

    Long-acting glucagon-like peptide-1 receptor agonist-status December 2018

    Holst, Jens Juul, 2019, In: Annals of Translational Medicine. 7, 5, 6 p., 83 .

    Research output: Contribution to journal › Editorial › Research

  9. Published

    Incretin-based therapy of metabolic disease

    Holst, Jens Juul, 2023, In: Danish Medical Journal. 70, 1, A10220597.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Glucagon-like peptide-1 (GLP-1): are its roles as endogenous hormone and therapeutic wizard congruent?

    Holst, Jens Juul, 2022, In: Journal of Internal Medicine. 291, 5, p. 557-573

    Research output: Contribution to journal › Review › Research › peer-review

  11. Published

    Treatment of Type 2 Diabetes and Obesity on the Basis of the Incretin System: The 2021 Banting Medal for Scientific Achievement Award Lecture

    Holst, Jens Juul, 2021, In: Diabetes. 70, 11, p. 2468-2475 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  12. Published

    Glucagon and other proglucagon-derived peptides in the pathogenesis of obesity

    Holst, Jens Juul, 2022, In: Frontiers in Nutrition. 9, 8 p., 964406.

    Research output: Contribution to journal › Review › Research › peer-review

  13. Published

    Discovery of the GI Effects of GLP-1: An Historical Perspective

    Holst, Jens Juul, 2022, In: Digestive Diseases and Sciences. 67, p. 2716-2720

    Research output: Contribution to journal › Review › Research › peer-review

  14. Published

    Bone resorption is decreased postprandially by intestinal factors and glucagon-like peptide-2 is a possible candidate

    Holst, Jens Juul, Hartmann, Bolette, Gottschalck, I. B., Jeppesen, Palle Bekker, Miholic, J. & Henriksen, D. B., Jul 2007, In: Scandinavian Journal of Gastroenterology. 42, 7, p. 814-20 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  15. Published

    Recent advances of GIP and future horizons

    Holst, Jens Juul & Rosenkilde, Mette, 2020, In: Peptides. 125, 6 p., 170230.

    Research output: Contribution to journal › Review › Research › peer-review

  16. Published

    Which to choose, an oral or an injectable glucagon-like peptide-1 receptor agonist?

    Holst, Jens Juul, 2019, In: The Lancet. 394, 10192, p. 4-6

    Research output: Contribution to journal › Editorial › Research › peer-review

  17. Published

    GLP-1 - Incretin and pleiotropic hormone with pharmacotherapy potential. Increasing secretion of endogenous GLP-1 for diabetes and obesity therapy

    Holst, Jens Juul, Jepsen, Sara Lind & Modvig, Ida Marie, 2022, In: Current Opinion in Pharmacology. 63, p. 1-7 102189.

    Research output: Contribution to journal › Journal article › Research › peer-review

  18. Published

    GIP as a Therapeutic Target in Diabetes and Obesity: Insight From Incretin Co-agonists

    Holst, Jens Juul & Rosenkilde, M. M., 2020, In: Journal of Clinical Endocrinology & Metabolism. 105, 8, p. E2710-E2716 7 p.

    Research output: Contribution to journal › Review › Research › peer-review

  19. Published

    Glucagon 100 years. Important, but still enigmatic

    Holst, Jens Juul, 2023, In: Peptides. 161, 6 p., 170942.

    Research output: Contribution to journal › Journal article › Research › peer-review

  20. Published

    Searching for the physiological role of glucose-dependent insulinotropic polypeptide

    Holst, Jens Juul, Windeløv, Johanne Agerlin, Boer, G. A., Pedersen, Jens, Svendsen, B., Christensen, M., Torekov, Signe Sørensen, Asmar, M., Hartmann, Bolette & Nissen, A., 1 Apr 2016, In: Journal of Diabetes Investigation. 7, S1, p. 8-12 5 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  21. Published

    From the Incretin Concept and the Discovery of GLP-1 to Today's Diabetes Therapy

    Holst, Jens Juul, 2019, In: Frontiers in Endocrinology. 10, 10 p., 260.

    Research output: Contribution to journal › Review › Research › peer-review

  22. Published

    The incretin system in healthy humans: The role of GIP and GLP-1

    Holst, Jens Juul, 2019, In: Metabolism. 96, p. 46-55

    Research output: Contribution to journal › Journal article › Research › peer-review

  23. Published

    Actions of glucagon-like peptide-1 receptor ligands in the gut

    Holst, Jens Juul, Andersen, Daniel Bjørklund & Grunddal, Kaare Villum, 2022, In: British Journal of Pharmacology. 179, 4, p. 727-742

    Research output: Contribution to journal › Review › Research › peer-review

  24. Published

    New Lessons from the gut: Studies of the role of gut peptides in weight loss and diabetes resolution after gastric bypass and sleeve gastrectomy

    Holst, Jens Juul, Madsbad, Sten, Bojsen-Møller, Kirstine Nyvold, Dirksen, C. & Svane, M., 2024, In: Peptides. 176, 9 p., 171199.

    Research output: Contribution to journal › Review › Research › peer-review

  25. Published

    Glucagon-like peptides 1 and 2, enteroglucagon, glicentin and oxyntomodulin

    Holst, Jens Juul, Deacon, Carolyn F., Hartmann, Bolette & Pedersen, Jens, 2013, Handbook of Biologically Active Peptides . Kastin, AJ. (ed.). 2 ed. Elsevier, p. 1241-1250 10 p.

    Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Education

Previous 1...5 6 7 8 9 10 11 12 ...23 Next